Anika Therapeutics Announces Third Quarter Results and Future Directions.
Business Wire › November 13, 2000
Linked as:
Extract
Anika Therapeutics Announces Third Quarter Results and Future Directions.
Business Editors and Health/Medical Writers
WOBURN, Mass.--(BW HealthWire)--Nov. 13, 2000 Anika Therapeutics, Inc. (Nasdaq:ANIK) today announced that revenue for the third quarter ending September 30, 2000 equaled $2,730,000 compared with $2,995,000 for the same period last year. The company recorded a net loss for the quarter of $1,383,000, or $.14 per share, versus a loss of $93,000, or $.01 per share, for the third quarter of 1999. Revenue for the nine-month period ending September 30, 2000 was $9,219,000 compared with $9,...See the full content of this document
Sponsored links
